Skip to main content
Log in

Nicorandil in angina: a favourable economic impact

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Walker A, McMurray J, Stewart S, Berger W, McMahon AD, Dargie H, Fox K, Hillis S, henderson NJK, Ford I.Economic evaluation of the impact of nicorandil in angina (IONA) trial. Heart 92: 619-624, No. 5, May 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nicorandil in angina: a favourable economic impact. Pharmacoecon. Outcomes News 507, 1 (2006). https://doi.org/10.2165/00151234-200605070-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605070-00001

Keywords

Navigation